# Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Page: https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/metastatic-triple-negative-breast-cancer-what-clinicians-want-to-know
Text version: https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/metastatic-triple-negative-breast-cancer-what-clinicians-want-to-know.md
Podcast: [Oncology Today with Dr Neil Love](https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241)
Published: 2026-06-26T13:00:00+00:00
Episode link: https://oncologytoday.captivate.fm/episode/6116-mtnbc26-1
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/83fd7ca7-44a2-480b-b83b-3fc58f935d3e.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/metastatic-triple-negative-breast-cancer-what-clinicians-want-to-know
Duration seconds: 3223

## Resource

Featuring perspectives from Dr Kevin Punie and Dr Tiffany A Traina, including the following topics: Introduction: Where We Are; Where We’re Heading (0:00) First-Line Treatment of BRCA Wild-Type Disease (9:14) First-Line Treatment of BRCA-Mutant Disease (38:48) Novel Approaches (47:49) CME information and select publications

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/metastatic-triple-negative-breast-cancer-what-clinicians-want-to-know/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/metastatic-triple-negative-breast-cancer-what-clinicians-want-to-know.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.